Search Results

Mubritinib (TAK 165) Evaluation Sample  | 99.6%

APEXBIO TECHNOLOGY LLC

Potent inhibitor of HER2/ErbB2 Tyrosine Kinase|HER2

More Information Supplier Page

×

Mubritinib (TAK 165)

Mubritinib (TAK 165) 10mg  | 99.6%

APEXBIO TECHNOLOGY LLC

Potent inhibitor of HER2/ErbB2 Tyrosine Kinase|HER2

More Information Supplier Page

×

Mubritinib (TAK 165)

Mubritinib (TAK 165) 25mg  | 99.6%

APEXBIO TECHNOLOGY LLC

Potent inhibitor of HER2/ErbB2 Tyrosine Kinase|HER2

More Information Supplier Page

×

Mubritinib (TAK 165)

Mubritinib (TAK 165) 200mg  | 99.6%

APEXBIO TECHNOLOGY LLC

Potent inhibitor of HER2/ErbB2 Tyrosine Kinase|HER2

More Information Supplier Page

×

Mubritinib (TAK 165)

TWS119 50mg  | 98%

APEXBIO TECHNOLOGY LLC

GSK-3β inhibitor PI3K/Akt/mTOR Signaling|GSK-3

More Information Supplier Page

×

TWS119

TWS119 20mg  | 98%

APEXBIO TECHNOLOGY LLC

GSK-3β inhibitor PI3K/Akt/mTOR Signaling|GSK-3

More Information Supplier Page

×

TWS119

TWS119 10mg  | 98%

APEXBIO TECHNOLOGY LLC

GSK-3β inhibitor PI3K/Akt/mTOR Signaling|GSK-3

More Information Supplier Page

×

TWS119

TWS119 10mM (in 1mL DMSO)  | 98%

APEXBIO TECHNOLOGY LLC

GSK-3β inhibitor PI3K/Akt/mTOR Signaling|GSK-3

More Information Supplier Page

×

TWS119

Tideglusib 200mg  | 98.45%

APEXBIO TECHNOLOGY LLC

non-ATP-competitive GSK-3β inhibitor PI3K/Akt/mTOR Signaling|GSK-3

More Information Supplier Page

×

Tideglusib

GSK-3 Inhibitor IX (BIO) 10mg  | 98.62%

APEXBIO TECHNOLOGY LLC

GSK-3α/GSK-3β inhibitor, cell-permeable, ATP-competitive and reversible PI3K/Akt/mTOR Signaling|GSK-3

More Information Supplier Page

×

GSK-3 Inhibitor IX (BIO)